Paper Details

Paper Title

A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.

Paper Journal Title

Neuro Oncol

Paper Citation Count

Paper Publication Year

2024

Bio Mention

+ T-cells, CD4 +, CD8, CD8 +, CNS WHO grade 2 LGG, IMA950, IMA950-reactive, LGG, PBMC, Patients, anti-CD27 antibody, anti-IMA950, effector memory T-cell, high-grade glioma, low-grade glioma, low-grade gliomas, patients, resected tumor, tumor, vaccine, varlilumab

Mesh Descriptor

Author Name	Affiliation
Nicholas Butowski	University of California san francisco
Nicholas Butowski	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Nicholas Butowski	University of California san francisco
Nicholas Butowski	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Annette M Molinaro	University of California san francisco
Annette M Molinaro	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Mariza Daras	University of California san francisco
Nancy Ann Oberheim Bush	University of California san francisco
Nancy Ann Oberheim Bush	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Nancy Ann Oberheim Bush	University of California san francisco
Nancy Ann Oberheim Bush	University of California san francisco
Nancy Ann Oberheim Bush	University of California san francisco
Nancy Ann Oberheim Bush	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Joanna J Phillips	University of California san francisco
Joanna J Phillips	University of California san francisco
Joanna J Phillips	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Joanna J Phillips	University of California san francisco
Joanna J Phillips	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Joanna J Phillips	University of California san francisco
Mitchel S Berger	University of California san francisco
Mitchel S Berger	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Mitchel S Berger	University of California san francisco
Mitchel S Berger	Helen Diller Family Comprehensive Cancer Center, University of California san francisco

1 - 23

Paper Details

Column Actions

Datasets